(Q38088252)

28 August 2017

title

Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors (English)

1 reference

28 August 2017

0 references

0 references

Daniel W Thorpe

1

1 reference

28 August 2017

Andrea M Stringer

series ordinal

2

1 reference

28 August 2017

Rachel J Gibson

series ordinal

3

1 reference

28 August 2017

language of work or name

1 reference

1 January 2013

1 reference

Experimental Biology and Medicine

28 August 2017

published in

1 reference

28 August 2017

volume

238

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

1-6

1 reference

Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Gastrointestinal mucositis: a new biological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Pathobiology of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

The pathobiology of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

The human gut microbiome: implications for future health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Metagenomic analysis of the human distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Irinotecan-induced mucositis is associated with changes in intestinal mucins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Bacteria and mucosal immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Structure of the intestinal flora responsible for development of the gut immune system in a rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

DAMPening inflammation by modulating TLR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Irinotecan changes gene expression in the small intestine of the rat with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Role of inducible heat shock protein 70 in radiation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Identification of Lps2 as a key transducer of MyD88-independent TIR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

TLR signaling in the gut in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

Gut microbiota: a potential new territory for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012260

21 January 2018

Identifiers

DOI

10.1258/EBM.2012.012260

1 reference

28 August 2017

1 reference